Invention Grant
![Substituted pyrrolo[2,3-b]-pyridines and -pyrazines](/docs/US/2013-11-26/US08592448B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted pyrrolo[2,3-b]-pyridines and -pyrazines
- Patent Title (中): 取代的吡咯并[2,3-b] - 吡嗪和吡嗪
-
Application No.: US13130113Application Date: 2009-11-19
-
Publication No.: US08592448B2Publication Date: 2013-11-26
- Inventor: Xin Chen , Melzhong Jin , Andrew Kleinberg , An-Hu Li , Mark J. Mulvihill , Arno G. Steinig , Jing Wang
- Applicant: Xin Chen , Melzhong Jin , Andrew Kleinberg , An-Hu Li , Mark J. Mulvihill , Arno G. Steinig , Jing Wang
- Applicant Address: US NY Farmingdale
- Assignee: OSI Pharmaceuticals, LLC
- Current Assignee: OSI Pharmaceuticals, LLC
- Current Assignee Address: US NY Farmingdale
- Agency: Astellas US LLC
- Agent Frank W. Forman
- International Application: PCT/US2009/065058 WO 20091119
- International Announcement: WO2010/059771 WO 20100527
- Main IPC: A61K31/437
- IPC: A61K31/437
![Substituted pyrrolo[2,3-b]-pyridines and -pyrazines](/abs-image/US/2013/11/26/US08592448B2/abs.jpg.150x150.jpg)
Abstract:
Compounds of Formula I, as shown below and defined herein: (I) pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers mediated at least in part by Ron and/or Met.
Public/Granted literature
- US20110224191A1 Substituted Pyrrolo[2,3-b]-Pyridines and -Pyrazines Public/Granted day:2011-09-15
Information query
IPC分类:
